Comparison of serum levels of cobalamine after giving a thrice weekly dose versus once weekly dose of methylcobalamin in patients suffering from peripheral neuropathy
Phase 4
- Conditions
- Health Condition 1: null- Peripheral neuropathy
- Registration Number
- CTRI/2017/02/007804
- Lead Sponsor
- Wockhardt limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 34
Inclusion Criteria
•Age > 18 years
•Subjects diagnosed with peripheral neuropathy through nerve conduction velocity test or healthy volunteers
•Ability to give written informed consent
Exclusion Criteria
•Females who are pregnant or lactating
•History of clinically significant metabolic, hepatic, renal, haematological, pulmonary, cardiovascular, gastrointestinal, urological, neurological or psychiatric disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum Cobalmine levels after multiple and single dose of trial medicationsTimepoint: baseline <br/ ><br>Day 8 <br/ ><br>Day 15
- Secondary Outcome Measures
Name Time Method adverse eventsTimepoint: at all visits;serum Homocysteine levelsTimepoint: baseline <br/ ><br>Day 8 <br/ ><br>Day 15